Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anakinra for flares of pyogenic arthritis in PAPA syndrome.
Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ. Dierselhuis MP, et al. Among authors: boelens jj. Rheumatology (Oxford). 2005 Mar;44(3):406-8. doi: 10.1093/rheumatology/keh479. Epub 2005 Jan 5. Rheumatology (Oxford). 2005. PMID: 15637033 No abstract available.
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.
Oved JH, Russell A, DeZern A, Prockop SE, Bonfim C, Sharma A, Purtill D, Lakkaraja M, Bidgoli A, Bhoopalan SV, Soni S, Boelens JJ, Abraham A. Oved JH, et al. Among authors: boelens jj. Cytotherapy. 2024 Sep 6:S1465-3249(24)00838-7. doi: 10.1016/j.jcyt.2024.09.001. Online ahead of print. Cytotherapy. 2024. PMID: 39320295 Free article.
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation.
Suwantarat N, Iamsirirak P, Chanapai J, Pakakasama S, Andersson BS, Boelens JJ, Anurathapan U, Hongeng S. Suwantarat N, et al. Among authors: boelens jj. Pediatr Blood Cancer. 2024 Nov;71(11):e31311. doi: 10.1002/pbc.31311. Epub 2024 Sep 3. Pediatr Blood Cancer. 2024. PMID: 39228048 No abstract available.
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity.
Bognàr T, Garcia-Rosa M, Lalmohamed A, Güngör T, Hauri-Hohl M, Prockop S, Oram L, Pai SY, Brooks J, Savic RM, Dvorak CC, Long-Boyle JR, Krajinovic M, Bittencourt H, Teyssier AC, Théorêt Y, Martinez C, Egberts TCG, Morales E, Slatter M, Cuvelier GDE, Chiesa R, Wynn RF, Coussons M, Cicalese MP, Ansari M, Long SE, Ebens CL, Lust H, Chaudhury S, Nath CE, Shaw PJ, Keogh SJ, van der Stoep MYEC, Bredius R, Lindemans CA, Boelens JJ, Bartelink IH. Bognàr T, et al. Among authors: boelens jj. Blood Adv. 2024 Oct 8;8(19):5137-5145. doi: 10.1182/bloodadvances.2024013275. Blood Adv. 2024. PMID: 39074263 Free PMC article.
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.
Gupta AO, Azul M, Bhoopalan SV, Abraham A, Bertaina A, Bidgoli A, Bonfim C, DeZern A, Li J, Louis CU, Purtill D, Ruggeri A, Boelens JJ, Prockop S, Sharma A. Gupta AO, et al. Among authors: boelens jj. Cytotherapy. 2024 Nov;26(11):1411-1420. doi: 10.1016/j.jcyt.2024.06.002. Epub 2024 Jun 6. Cytotherapy. 2024. PMID: 38970612
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Horwitz SM, Nirmal AJ, Rahman J, Xu R, Drill E, Galasso N, Ganesan N, Davey T, Hancock H, Perez L, Maccaro C, Bahgat A, Marzouk E, Cathcart E, Moskowitz A, Noy A, Kumar A, Jacobsen E, Fisher DC, Mehta-Shah N, Kim YH, Khodadoust M, Kotlov N, Nikitina A, Kudryashova O, Zubareva V, Zornikova K, Shin N, Sorokina M, Degryse S, Postovalova E, Bagaev A, Hosszu K, McAvoy D, Boelens JJ, Wu W, Ciantra Z, Appelt JW, Trevisani C, Amaka S, Weinstock DM, Vardhana SA. Horwitz SM, et al. Among authors: boelens jj. Nat Med. 2024 Sep;30(9):2517-2527. doi: 10.1038/s41591-024-03076-6. Epub 2024 Jun 17. Nat Med. 2024. PMID: 38886623 Clinical Trial.
282 results